Skip to main content
hello world

Closing Bell: Arch Biopartners Inc up on Friday (ARCH)

Automated Summaries - The Globe and Mail - Fri Aug 2, 4:01PM CDT

Today, shares of Arch Biopartners Inc opened at $1.53 and closed at $1.55. It traded at a low of $1.51 to a high of $1.58.

The price advanced 2.65 percent from the previous day's close of $1.51.

During the day across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -1.37% at 5446.68, the Dow Jones Industrial Average closed -1.21% at 40347.97 and the Nasdaq Composite closed -2.30% at 17194.15.

Arch Biopartners Inc traded under ARCH on the Toronto Venture Exchange (TSX-V).

A total of 24,617 shares was traded during the session, with total trades of 32. On average, Arch Biopartners Inc has traded 19,038 shares over the last 5-days and 23,004 year-to-date.

The TSX-V overall saw 741 price advancers against 4,512 declines and 69 unchanged.

During the prior 52 weeks, ARCH.VN has traded as high as $2.56 (March 18,2024) and low as $0.97 (November 03,2023). Moreover, the shares have shrunken -24.76 percent in 52 weeks, while they have advanced 4.73% this year.

It announced a 0.05 dividend on January 01/70, with an December 05/89 ex-date and January 01/70 pay day.

Following today's trading, Arch Biopartners Inc has a market capitalization of $96.41 million on a float of 63,851 shares outstanding. Its annual EPS is $-0.03.

Arch Biopartners Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Currently, Arch Biopartners Inc's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..